Abbott Laboratories (ABT): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Abbott Laboratories ( ABT) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.4%. By the end of trading, Abbott Laboratories rose $0.40 (1.0%) to $39.79 on average volume. Throughout the day, 9,140,499 shares of Abbott Laboratories exchanged hands as compared to its average daily volume of 7,373,500 shares. The stock ranged in a price between $39.33-$39.83 after having opened the day at $39.35 as compared to the previous trading day's close of $39.39. Other companies within the Health Services industry that increased today were: BioTelemetry ( BEAT), up 13.6%, Fonar Corporation ( FONR), up 13.2%, Oculus Innovative ( OCLS), up 9.3% and Akers Biosciences ( AKER), up 8.0%.

Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of health care products worldwide. Abbott Laboratories has a market cap of $60.6 billion and is part of the health care sector. Shares are up 2.8% year to date as of the close of trading on Wednesday. Currently there are 10 analysts that rate Abbott Laboratories a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Abbott Laboratories as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and impressive record of earnings per share growth. However, as a counter to these strengths, we find that net income has been generally deteriorating over time.

On the negative front, InspireMD ( NSPR), down 14.3%, BioScrip ( BIOS), down 12.3%, Catamaran ( CTRX), down 10.9% and Lakeland Industries ( LAKE), down 5.5%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Roku, Amazon, Teladoc, Weyerhaeuser: 'Mad Money' Lightning Round

Roku, Amazon, Teladoc, Weyerhaeuser: 'Mad Money' Lightning Round

Volatility Is Still in Charge: Cramer's 'Mad Money' Recap (Friday, 2/9/18)

Volatility Is Still in Charge: Cramer's 'Mad Money' Recap (Friday, 2/9/18)

Cramer: 10 Points to Consider

Cramer: 10 Points to Consider

The 5 Best Dividend Aristocrats For 2018

The 5 Best Dividend Aristocrats For 2018

Lam Research: Cramer's Top Takeaways

Lam Research: Cramer's Top Takeaways